Keros Therapeutics (KROS) FCF Margin (2019 - 2025)
Keros Therapeutics posted quarterly FCF Margin of 4485.27% for Q4 2025, down 1359885.0% year-on-year from N/an in Q4 2024, and down 34752.71% on a QoQ basis from 12.94% in Q3 2025.
Keros Therapeutics (KROS) has 6 years of FCF Margin data on file, last reported at 4485.27% in Q4 2025.
- For the quarter ending Q4 2025, FCF Margin fell 1359885.0% year-over-year to 4485.27%; the trailing twelve-month figure through Dec 2025 stood at 44.01% (down 13562265.0% YoY), and the FY2025 full-year result was 44.05%, changed N/A from the prior year.
- FCF Margin for Q4 2025 stood at 4485.27%, down from 12.94% in the prior quarter.
- Across five years, FCF Margin topped out at 9113.58% in Q4 2024 and bottomed at 408362.5% in Q3 2023.
- The 5-year median for FCF Margin is 160.02% (2025), against an average of 40793.06%.
- The widest annual swing landed in 2024, when FCF Margin soared 40010013 bps; it then tumbled 1359885 bps in 2025.
- A 5-year view of FCF Margin shows it stood at 110.19% in 2021, then jumped by 92 bps to 8.41% in 2022, then tumbled by 216048 bps to 18180.42% in 2023, then surged by 150 bps to 9113.58% in 2024, then plunged by 149 bps to 4485.27% in 2025.
- The last three FCF Margin figures came in at 4485.27% (Q4 2025), 12.94% (Q3 2025), and 160.02% (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -3.98% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 43.35% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 23.53% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 4.17% |
| 10 | Keros Therapeutics | 403.85 Mn | 116.45 Mn | - | -4,485.27% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -4,485.27% |
| Sep 30, 2025 | 12.94% |
| Jun 30, 2025 | -160.02% |
| Mar 31, 2025 | 76.03% |
| Dec 31, 2024 | 9,113.58% |
| Sep 30, 2024 | -8,262.37% |
| Dec 31, 2023 | -18,180.42% |
| Sep 30, 2023 | -408,362.50% |
| Mar 31, 2022 | -8.41% |
| Dec 31, 2021 | -110.19% |
| Jun 30, 2021 | -18,357.00% |
| Dec 31, 2019 | -220.64% |
| Sep 30, 2019 | -121.48% |
| Jun 30, 2019 | -208.12% |
| Mar 31, 2019 | -100.52% |